Intellia Therapeutics

NTLA

NTLA
Intellia Therapeutics Stock Quote
$10.93 -$0.42 -3.7%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT View Interactive NTLA Charts

Intellia Therapeutics, Inc. Common Stock

News & Analysis: Intellia Therapeutics

All

Market Moves

Earnings


Is Intellia Therapeutics a Buy?

The CRISPR pioneer is taking a slow-and-steady approach to drug development. If peers are overlooking one key element of gene editing, that approach could pay off.







5 Top Gene-Editing Stocks for 2019

The future of treating disease might be gene editing, and these five stocks have the most promising technologies.




Interactive Chart